Concepedia

Myra Langendonk

ML

5

Publications

96

Citations

5

H-Index

2016

Active since

Affiliations

University of Groningen(Current)

University Medical Center Groningen

Myra Langendonk is an author at University of Groningen specializing in tumor biology, immunology, and medicine.

ORCID

Top concepts

Publications per year

2016–2022

5

Publications

5

WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage

Mathilde R. W. de Jong, Myra Langendonk, Bart Reitsma et al. · Cancers · 2019 · 27 citations · Full text

, , +16

Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma

Mathilde R. W. de Jong, Myra Langendonk, Bart Reitsma et al. · International Journal of Molecular Sciences · 2019 · 21 citations · Full text

, , +18

Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma

Myra Langendonk, Mathilde R. W. de Jong, Nienke Smit et al. · Blood Cancer Journal · 2022 · 20 citations · Full text

WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma

Mathilde R. W. de Jong, Myra Langendonk, Bart Reitsma et al. · Therapeutic Advances in Hematology · 2020 · 15 citations · Full text

Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas

Rui Wu, Marcel Nijland, Bea Rutgers et al. · PLoS ONE · 2016 · 13 citations · Full text

, , +20

Rows per page

1–5 of 5